视黄酸受体β在肝细胞癌与肝硬化中下调且其表达抑制肝星状细胞的肌球蛋白驱动活化与杜罗轴趋性
肝星状细胞(HSC)在肝纤维化中活化并促进细胞外基质沉积与组织僵硬,在肝细胞癌(HCC)中活化的HSC浸润间质并向肿瘤核心迁移。本研究发现视黄酸受体β(RAR-β)在肝硬化和HCC组织中表达显著降低,全反式视黄酸通过RAR-β依赖的转录下调肌球蛋白轻链2表达促进HSC去活化,并消除向更硬基底迁移的机械驱动迁移。
要点
- RAR-β在肝硬化和HCC组织中表达显著降低。
- 全反式视黄酸经RAR-β依赖的转录下调肌球蛋白轻链2表达,促进HSC去活化。
- 该通路消除HSC向更硬基底迁移的机械驱动迁移,靶向HSC机械转导或为肝病治疗提供选择。
核心结论
- 在转录水平靶向肝星状细胞的机械转导可能为多种肝病提供治疗选择。
研究设计与样本
- 研究检测肝硬化与肝细胞癌患者组织中RAR-β的表达谱,并分析RAR-β激活对肝星状细胞的影响,采用综合生物物理方法结合细胞与分子生物学。
主要发现
- RAR-β在肝硬化和HCC组织中表达显著降低。
- 全反式视黄酸通过RAR-β依赖的转录下调肌球蛋白轻链2表达,促进HSC去活化。
- 该作用消除HSC向更硬基底迁移的机械驱动迁移。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatic stellate cells (HSCs) are essential perisinusoidal cells in both healthy and diseased liver. HSCs modulate extracellular matrix (ECM) homeostasis when quiescent, but in liver fibrosis, HSCs become activated and promote excess deposition of ECM molecules and tissue stiffening via force generation and mechanosensing. In hepatocellular carcinoma (HCC), activated HSCs infiltrate the stroma and migrate to the tumor core to facilitate paracrine signaling with cancer cells. Because the function of HSCs is known to be modulated by retinoids, we investigated the expression profile of retinoic acid receptor beta (RAR-β) in patients with cirrhosis and HCC, as well as the effects of RAR-β activation in HSCs. We found that RAR-β expression is significantly reduced in cirrhotic and HCC tissues. Using a comprehensive set of biophysical methods combined with cellular and molecular biology, we have elucidated the biomechanical mechanism by which all trans-retinoic acid promotes HSC deactivation via RAR-β-dependent transcriptional downregulation of myosin light chain 2 expression. Furthermore, this also abrogated mechanically driven migration toward stiffer substrates. Conclusion: Targeting mechanotransduction in HSCs at the transcriptional level may offer therapeutic options for a range of liver diseases.
引用
- Cortes E, Lachowski D, Rice A, et al. Retinoic Acid Receptor-β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin-Driven Activation and Durotaxis in Hepatic Stellate Cells. Hepatology. 2018. PMID: 30055117. doi:10.1002/hep.30193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。